PulmCCM

PulmCCM

Share this post

PulmCCM
PulmCCM
SELECT2 trial: endovascular therapy for large ischemic stroke
Copy link
Facebook
Email
Notes
More

SELECT2 trial: endovascular therapy for large ischemic stroke

PulmCCM's avatar
PulmCCM
May 06, 2023
∙ Paid

Share this post

PulmCCM
PulmCCM
SELECT2 trial: endovascular therapy for large ischemic stroke
Copy link
Facebook
Email
Notes
More
Share

Endovascular thrombectomy for large ischemic stroke came to prominence based on limited data showing its efficacy in patients with smaller strokes; large strokes were excluded. The SELECT2 randomized trial enrolling 178 patients with large ischemic strokes was stopped early for efficacy after an impressive 20% of patients achieved functional independenc…

Keep reading with a 7-day free trial

Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 PulmCCM LLC
Publisher Terms
Substack
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More